Bottom line
RSPH vs RAGHX: the short answer
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and RAGHX (Virtus KAR Health Sciences Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared.
But RSPH is far broader, holding 63 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.
RSPH is cheaper at 0.4% vs 1.41% — a difference of $101 a year per $10,000 invested.
Over five years, RSPH returned +4.7% a year vs +2.4% for RAGHX.
RAGHX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
RSPH vs RAGHX side by side
| RSPH | RAGHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Invesco | Virtus |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.4% | 1.41% |
| Annual cost per $10k | $40 | $141 |
| 10-yr cost on $10k (prospectus) | $505 | $2,148 |
| Max front load | None | 5.5% |
| 12b-1 fee | — | 0.25% |
| 1-yr return | +9.3% | +1.3% |
| 5-yr return (annualized) | +4.7% | +2.4% |
| 10-yr return (annualized) | +8.2% | +6.2% |
| Best quarter | +17.5% | — |
| Worst quarter | −14.3% | — |
| Net assets (fund) | $766.9M | $91.7M |
| Number of holdings | 63 | 24 |
| Portfolio turnover | 24% | 13% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
6 of RSPH's top 25 holdings also appear in RAGHX's top 24.
| Holding | RSPH | RAGHX |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 1.96% | 2.90% |
| Mettler-Toledo International Inc. | 1.94% | 3.99% |
| Thermo Fisher Scientific Inc. | 1.84% | 3.65% |
| Amgen Inc. | 1.77% | 3.85% |
| DexCom, Inc. | 1.73% | 3.05% |
| AbbVie Inc. | 1.73% | 5.52% |
Source: SEC Form N-PORT
RSPH top 10
- Bio-Techne Corp. — 2.13%
- IQVIA Holdings Inc. — 2.00%
- Baxter International Inc. — 1.99%
- Regeneron Pharmaceuticals, Inc. — 1.96%
- Mettler-Toledo International Inc. — 1.94%
- Charles River Laboratories International, Inc. — 1.93%
- Veeva Systems Inc. — 1.93%
- DaVita Inc. — 1.87%
- Moderna, Inc. — 1.85%
- Thermo Fisher Scientific Inc. — 1.84%
RAGHX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
FAQ
What is the difference between RSPH and RAGHX?
Which is cheaper, RSPH or RAGHX?
Should I own both RSPH and RAGHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.